CN115336649A - Tea drink composition for health food and application thereof - Google Patents
Tea drink composition for health food and application thereof Download PDFInfo
- Publication number
- CN115336649A CN115336649A CN202210678885.5A CN202210678885A CN115336649A CN 115336649 A CN115336649 A CN 115336649A CN 202210678885 A CN202210678885 A CN 202210678885A CN 115336649 A CN115336649 A CN 115336649A
- Authority
- CN
- China
- Prior art keywords
- parts
- drink composition
- tea drink
- tea
- epidemic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 45
- 235000013402 health food Nutrition 0.000 title claims abstract description 20
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 35
- 201000010099 disease Diseases 0.000 claims abstract description 34
- 206010035737 Pneumonia viral Diseases 0.000 claims abstract description 13
- 208000009421 viral pneumonia Diseases 0.000 claims abstract description 13
- 244000124853 Perilla frutescens Species 0.000 claims abstract description 9
- 235000004347 Perilla Nutrition 0.000 claims abstract description 8
- 208000035473 Communicable disease Diseases 0.000 claims abstract description 7
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 7
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 7
- 244000274050 Platycodon grandiflorum Species 0.000 claims abstract description 7
- 235000006533 astragalus Nutrition 0.000 claims abstract description 7
- 241000132012 Atractylodes Species 0.000 claims abstract description 6
- 235000006753 Platycodon grandiflorum Nutrition 0.000 claims abstract description 6
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 6
- 235000011477 liquorice Nutrition 0.000 claims abstract description 6
- 241000045403 Astragalus propinquus Species 0.000 claims abstract description 5
- 239000004480 active ingredient Substances 0.000 claims abstract description 3
- 230000000241 respiratory effect Effects 0.000 claims abstract description 3
- 244000269722 Thea sinensis Species 0.000 claims abstract 10
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract 2
- 239000003814 drug Substances 0.000 claims description 52
- 210000002345 respiratory system Anatomy 0.000 claims description 19
- 239000008187 granular material Substances 0.000 claims description 12
- 230000003612 virological effect Effects 0.000 claims description 11
- 239000000843 powder Substances 0.000 claims description 10
- 238000002360 preparation method Methods 0.000 claims description 10
- 208000015181 infectious disease Diseases 0.000 claims description 7
- 206010022000 influenza Diseases 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 4
- 239000008297 liquid dosage form Substances 0.000 claims description 4
- 239000006187 pill Substances 0.000 claims description 4
- 239000007909 solid dosage form Substances 0.000 claims description 4
- 239000002552 dosage form Substances 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 239000002775 capsule Substances 0.000 claims description 2
- 239000003086 colorant Substances 0.000 claims description 2
- 239000007938 effervescent tablet Substances 0.000 claims description 2
- 239000000945 filler Substances 0.000 claims description 2
- 239000000796 flavoring agent Substances 0.000 claims description 2
- 235000013355 food flavoring agent Nutrition 0.000 claims description 2
- 239000000314 lubricant Substances 0.000 claims description 2
- 239000002674 ointment Substances 0.000 claims description 2
- 239000003755 preservative agent Substances 0.000 claims description 2
- 208000020029 respiratory tract infectious disease Diseases 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 239000002671 adjuvant Substances 0.000 claims 2
- 239000011230 binding agent Substances 0.000 claims 1
- -1 decoctions Substances 0.000 claims 1
- 239000007884 disintegrant Substances 0.000 claims 1
- 239000008180 pharmaceutical surfactant Substances 0.000 claims 1
- 235000013616 tea Nutrition 0.000 abstract description 42
- 239000000463 material Substances 0.000 abstract description 25
- 235000013305 food Nutrition 0.000 abstract description 16
- 238000005728 strengthening Methods 0.000 abstract description 10
- 230000008901 benefit Effects 0.000 abstract description 5
- 230000000694 effects Effects 0.000 abstract description 5
- 230000006806 disease prevention Effects 0.000 abstract description 4
- 208000037797 influenza A Diseases 0.000 abstract description 4
- 238000000034 method Methods 0.000 abstract description 4
- 235000013376 functional food Nutrition 0.000 abstract description 3
- 230000009286 beneficial effect Effects 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 241001122767 Theaceae Species 0.000 description 27
- 230000002265 prevention Effects 0.000 description 25
- 229940079593 drug Drugs 0.000 description 17
- 206010035664 Pneumonia Diseases 0.000 description 15
- 230000001717 pathogenic effect Effects 0.000 description 15
- 241000711573 Coronaviridae Species 0.000 description 12
- 239000002994 raw material Substances 0.000 description 11
- 210000004072 lung Anatomy 0.000 description 9
- 240000000249 Morus alba Species 0.000 description 6
- 235000008708 Morus alba Nutrition 0.000 description 6
- 244000052769 pathogen Species 0.000 description 6
- 241001570521 Lonicera periclymenum Species 0.000 description 5
- 235000002226 Ranunculus ficaria Nutrition 0.000 description 4
- 241001530126 Scrophularia Species 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 229940107666 astragalus root Drugs 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 230000003449 preventive effect Effects 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 241001061264 Astragalus Species 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 241000229182 Ledebouriella seseloides Species 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 235000006751 Platycodon Nutrition 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 241001180876 Saposhnikovia Species 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000007123 defense Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- 239000010977 jade Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 229930189914 platycodon Natural products 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 210000004233 talus Anatomy 0.000 description 2
- 229940126680 traditional chinese medicines Drugs 0.000 description 2
- 229960005486 vaccine Drugs 0.000 description 2
- 244000291564 Allium cepa Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 241000092665 Atractylodes macrocephala Species 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 240000008917 Glycyrrhiza uralensis Species 0.000 description 1
- 235000000554 Glycyrrhiza uralensis Nutrition 0.000 description 1
- 235000017443 Hedysarum boreale Nutrition 0.000 description 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 241000100289 Lonicera confusa Species 0.000 description 1
- 241000173699 Lonicera dasystyla Species 0.000 description 1
- 241001170080 Lonicera hypoglauca Species 0.000 description 1
- 244000167230 Lonicera japonica Species 0.000 description 1
- 235000017617 Lonicera japonica Nutrition 0.000 description 1
- 241000218231 Moraceae Species 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 235000004348 Perilla frutescens Nutrition 0.000 description 1
- 240000003582 Platycodon grandiflorus Species 0.000 description 1
- 241001121987 Scrophularia ningpoensis Species 0.000 description 1
- 241000207844 Scrophulariaceae Species 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 210000001989 nasopharynx Anatomy 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 239000009571 yupingfeng Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/34—Tea substitutes, e.g. matè; Extracts or infusions thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/346—Platycodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/535—Perilla (beefsteak plant)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/808—Scrophularia (figwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention belongs to the technical field of functional foods, and particularly relates to a tea drink composition for health-care foods and application thereof. The tea drink composition comprises the following main active ingredients in parts by mass: 10-20 parts of astragalus membranaceus, 5-15 parts of bighead atractylodes rhizome, 5-15 parts of folium mori, 5-15 parts of perilla leaf, 5-15 parts of honeysuckle, 5-12 parts of platycodon grandiflorum, 5-15 parts of radix scrophulariae and 3-10 parts of liquorice. The invention also provides application of the tea drink composition. The tea beverage composition provided by the invention adopts a method of strengthening body resistance and eliminating evil, completely adopts medicinal and edible traditional Chinese medicinal materials, has the effects of tonifying qi and strengthening exterior, and clearing away heat and toxic materials, and can be beneficial to preventing epidemic and/or non-epidemic respiratory infectious diseases (such as novel coronary viral pneumonia and influenza A). The tea drink composition has obvious advantages on applicable people as a health food, can be widely applied to susceptible people without epidemic disease in the epidemic disease prevention stage, and has the advantages of good safety, reasonable formula, pertinence and strong practicability.
Description
Technical Field
The invention belongs to the technical field of functional foods, and particularly relates to a tea drink composition for health-care foods and application thereof.
Background
In recent years, a wide range of viral infectious respiratory diseases, particularly novel coronavirus pneumonia (hereinafter referred to as "new coronavirus pneumonia"), have occurred worldwide, and the novel coronavirus has many variations, strong infectivity, and rapid spread. The prevention is well done, and the prevention of epidemic spread is the key point of epidemic prevention. At present, the prevention measure of the western medicine for the viral pneumonia such as the new coronary pneumonia is vaccine injection. However, the novel coronavirus has high mutation speed, the novel variant strain can become a main global epidemic strain in about 3-6 months from an early alpha and delta strain to a newly-appeared Onckh strain, and a preventive specific immune vaccine always tracks the development of the variant virus and is very passive.
The traditional Chinese medicine considers that: respiratory viral infectious diseases such as new coronary pneumonia, influenza and the like belong to the category of epidemic diseases and pestilence of the traditional Chinese medicine. The idea of epidemic disease prevention and treatment from Huangdi's classic on medicine includes the disease prevention concept of ' healthy qi exists in the interior, and the pathogens cannot be dried up ' and ' the disease is not treated but is not treated before the disease is treated ', then the pestilence system for preventing and treating infectious diseases is gradually formed from the theory of typhoid fever to the theory of epidemic febrile disease, and the concept of ' prevention ' of epidemic diseases is deeply embedded in the theory of civil and traditional Chinese medicine.
In order to fully exert the function of traditional Chinese medicines in prevention and control of epidemic diseases such as new coronary pneumonia, a traditional Chinese medicine prevention and treatment scheme for new coronary pneumonia is published in a plurality of provinces and cities in China, however, one or more traditional Chinese medicinal materials in traditional Chinese medicine prevention and treatment formulas for susceptible people not infected with new coronary pneumonia viruses disclosed in the traditional Chinese medicine prevention and treatment scheme for new coronary pneumonia belong to medicinal materials in a list of articles which are both food and medicine (or a material list of foods and medicines) or a list of articles which can be used for health-care food (or a health-care food raw material list), and the traditional Chinese medicine prevention formula belongs to a medicinal formula (namely a traditional Chinese medicine formula containing non-edible traditional Chinese medicinal materials except the two lists). As a measure in the prevention stage, the popularization of adopting a medicinal prescription as a prevention means aiming at susceptible people (including normal people in a non-disease state or people suffering from other diseases) not infected with the current infectious diseases does not meet the safety or medicine supervision requirements of medical ethics, and has certain potential safety hazard, so that a plurality of traditional Chinese medicine prevention prescriptions are not suitable for being taken by the susceptible people at present. In addition, the drug prescription needs to be strictly subjected to drug registration management before the product is marketed, the marketing period is long, and quick emergency response cannot be performed when relevant epidemic situation comes, so that the scope and the effect of epidemic situation prevention and control can be influenced to a certain extent.
Because the prevention scheme of the new coronary pneumonia is usually formulated together with the prevention and treatment scheme, the formulators mostly adopt clinical medical experts which generally think that the related traditional Chinese medicinal materials have small side effect and are commonly used in clinic, and therefore, the change of the drug administration objects in the prevention stage is not concerned. In fact, the susceptible population is significantly different from the clinically diagnosed patient, and the related regulatory requirements and measures of the drugs used by the susceptible population are completely different. Therefore, there is a need to develop a non-medicinal prescription for effectively preventing the occurrence of epidemic diseases such as new coronary pneumonia, etc., so as to satisfy the epidemic prevention requirements of a large number of susceptible people (including normal people in non-disease state or people suffering from other diseases) not infected with the current infectious diseases.
Disclosure of Invention
The first object of the present invention is to provide a tea drink composition for health food. The second object of the present invention is to provide the use of the tea drink composition for health food.
According to the first object of the invention, the tea drink composition for the health food is provided, and the main active ingredients of the tea drink composition comprise the following components in parts by mass: 10-20 parts of astragalus membranaceus, 5-15 parts of bighead atractylodes rhizome, 5-15 parts of folium mori, 5-15 parts of perilla leaf, 5-15 parts of honeysuckle, 5-12 parts of platycodon grandiflorum, 5-15 parts of radix scrophulariae and 3-10 parts of liquorice.
The sources of the raw material medicaments of the invention are as follows:
astragalus root: dried root of Astragalus membranaceus bge. Var. Mongholicus (bge.) or Astragalus membranaceus bge.
White atractylodes rhizome: dried rhizome of Atractylodes macrocephala Koidz of Compositae.
Mulberry leaf: dried leaves of Morus alba L. Of Moraceae.
Perilla leaf: dried leaves (or with shoots) of Perilla frutescens (L.) Britt, a Labiatae plant.
Balloon flower: dried root of Platycodon grandiflorum (jacq.) a.dc.
Honeysuckle flower: <xnotran> Lonicera japonica Thunb., Lonicera hypoglauca Miq., () Lonicera confusa DC. Lonicera dasystyla Rehd. . </xnotran>
Figwort root: radix scrophulariae Scrophulariae, scrophulariaceae, scrophularia ningpoensis Hemsl.
Licorice root: root and rhizome of Glycyrrhiza uralensis Fisch.
In some embodiments, the tea composition may be in a solid dosage form or a liquid dosage form, wherein the solid dosage form may be a granule, a powder, a tablet, an effervescent tablet, a capsule, a pill, a drop pill or a tea bag, and the liquid dosage form may be a decoction, a mixture, an oral liquid or an ointment.
In some embodiments, the tea beverage composition further comprises pharmaceutically acceptable auxiliary materials, wherein the auxiliary materials are one or more of filling agent, adhesive, disintegrating agent and lubricant, and one or more of flavoring agent, coloring agent, preservative and medicinal surfactant.
The tea composition can be prepared into corresponding dosage forms according to the existing preparation method of traditional Chinese medicines.
In the preparation process, according to actual needs, one part of medicinal materials in the raw material formula of the tea composition can be directly crushed, the other part of medicinal materials are prepared into extract powder, then the crushed medicinal materials and the extract powder are uniformly mixed to form intermediate raw materials, and a final preparation form is formed according to the requirements of different solid or liquid preparation forms, for example, the intermediate raw materials are filled into a tea bag according to the requirements of the tea bag to obtain the tea bag; or crushing all the medicinal materials in the raw material formula of the tea beverage composition or preparing all the medicinal materials into extract powder, then uniformly mixing the crushed medicinal materials or the extract powder to form intermediate raw materials, and then forming a final preparation according to the requirements of different solid or liquid preparation formulations, for example, filling the intermediate raw materials into a tea bag according to the requirements of the tea bag to obtain the tea bag preparation.
In addition, the single medicine formula granules purchased from the market can be mixed according to the proportion to obtain the formula granule electuary; or using the formula granules as intermediate raw materials, and forming final dosage forms according to the requirements of different solid or liquid dosage forms, for example, filling the intermediate raw materials into tea bags according to the requirements of tea bags to obtain tea bags.
The tea composition can be prepared by boiling ginger and fistular onion stalk or taken together with the boiled water in cold seasons or under cold conditions for a long time.
According to a second object of the present invention, there is provided a use of the above tea beverage composition for health foods in the preparation of health foods for preventing respiratory tract external diseases.
Exogenous disease refers to the disease of the body caused by invasion of exogenous pathogenic factors. The respiratory tract exogenous disease referred by the invention is particularly the respiratory tract exogenous disease called as 'wind pathogen is suffered up and first invades lung' in traditional Chinese medicine, and belongs to the category of 'epidemic disease' and 'pestilence' in traditional Chinese medicine. The Chinese medicine considers that the basic characteristics of wind evil are as follows: the Chinese medicament is easy to carry out without normality, has uncertainty of multiple change ends, no hole and no input, is easy to cause diseases and is easy to spread and spread; and its manifestations are also varied after feeling wind evil. Wind pathogen belongs to yang pathogen, and according to the principle of competing with qi, it firstly invades the upper jiao, and in the upper jiao, the lung is the delicate organ, most susceptible to pathogen, so the first manifestation of lung qi invasion and damage occurs. The epidemic and/or non-epidemic respiratory tract (upper respiratory tract and lower respiratory tract) infectious diseases in modern medicine belong to the category of respiratory tract external infection diseases, wherein the respiratory tract infectious diseases comprise viral cold and viral pneumonia, the viral cold comprises influenza A and the viral pneumonia comprises novel coronary viral pneumonia.
The tea drink composition is used as a health food, is suitable for preventing respiratory tract exogenous diseases of wide susceptible people, and is mainly characterized in that:
the tea composition provided by the invention is prepared according to the following three principles: (1) the composition is completely composed of medicinal and edible traditional Chinese medicinal materials, (2) strengthening body resistance and (3) eliminating evil, so that the tea beverage composition has good edible safety, outstanding compatibility pertinence and feasible emergency practicability, and specifically:
(1) Good edible safety
The raw medicinal materials used in the invention belong to traditional Chinese medicinal materials in a list of articles which are both food and medicine (mulberry leaf, perilla leaf, honeysuckle, platycodon root and liquorice) and a list of articles which can be used for health food (astragalus, bighead atractylodes rhizome and figwort root), and the safety and the effectiveness of the traditional Chinese medicinal materials in the two lists (or catalogues) are approved by the national food and drug administration, so that the traditional Chinese medicinal materials are allowed to be used as health food for record management without additional approval. Therefore, the raw materials used in the invention have the characteristics of homology of medicine and food and safe medication, the edible safety is fully guaranteed, the health-care food is convenient to be used by people without epidemic diseases in a prevention stage, the health-care food has obvious advantages in applicable people, and a prevention scheme can meet the application requirements in a large range.
(2) Outstanding compatibility pertinence
The invention considers that the prevention of epidemic diseases needs to play a role in strengthening body resistance and eliminating evil. Healthy qi is the adaptive capacity, defense capacity and health recovery capacity of the body to the external environment, and is basically consistent with the immune function; pathogenic qi refers to pestilence (various toxins, pathogenic microorganisms, etc.). The dominant status of healthy qi and the external condition of pathogenic qi determine the development of disease.
Strengthening body resistance (improving immunity or resistance): the Qing Dynasty doctor who inherits the book of 'Ready to read' for the Jade Screen powder has an exquisitely reading: the middle warmer is established first for all cases with exterior deficiency failing to defend the body, so the spleen-tonifying middle warmer is the monarch drug for Atractylodis rhizoma, while the spleen-tonifying middle warmer is the dominant drug for the four zang organs, and the exterior is self-consolidating without pathogenic dryness; moreover, the astragalus root can strengthen the exterior and strengthen the defense, so that the people who walk well and get the wind-proof are afraid of each other, and the functions of the people are out of the middle, the astragalus root can not worry about the strengthening of the pathogens, and the wind-proof can not worry about the dispersing of the exterior, so that the dispersing can tonify the interior and dredge the interior.
However, the ledebouriella seseloides contained in the jade screen powder does not belong to the traditional Chinese medicinal materials in the article list of food and medicine or the article list of health food, and has certain limitations in the aspects of edible safety and medication management, so that the jade screen powder or other traditional Chinese medicine compositions containing ledebouriella seseloides cannot be directly and completely popularized and used in susceptible people as a traditional Chinese medicine prevention prescription.
According to the clinical experience of an inventor, the invention adopts the Yupingfeng powder as a main formula to replace the divaricate saposhnikovia root by mulberry leaves and perilla leaves, the mulberry leaves have the functions of gently lifting and floating, and can well disperse wind-heat and clear lung heat, the perilla leaves can ventilate lung and relieve exterior syndrome, promote qi circulation and reduce phlegm, the two medicines are used together to ventilate lung qi and promote movement, specially attack and relieve exterior syndrome and eliminate pathogenic factors (exogenous pathogenic factors), and the invention can be used for successfully replacing the divaricate saposhnikovia root, and is particularly suitable for the respiratory tract exogenous diseases caused by wind evil.
Eliminating pathogenic factors: according to the characteristics that the pathogenic factors are mostly warm or easily enter the interior to transform heat in the theory of warm disease in traditional Chinese medicine, aiming at the main symptoms of dryness and swelling of the nasopharynx part caused by the upward attack of the warm pathogenic factors, the medicines are selected according to the principle of clearing lung heat, moistening lung dryness and relieving sore throat, and the medicines for clearing heat, removing toxicity, moistening lung and relieving sore throat are adopted: honeysuckle, platycodon grandiflorum, figwort and liquorice. The four medicines are used together to assist the principal prescription of monarch medicine to exert the targeted action of eliminating pathogenic factors.
Therefore, the invention takes 'strengthening body resistance and eliminating evil' as a principle, eliminates evil on the basis of strengthening body resistance, improves human immunity, simultaneously eliminates pestilence and toxicity evil, and accords with the compatibility principle of disease prevention and treatment in traditional Chinese medicine.
The whole formula of the tea beverage composition has the effects of tonifying qi, strengthening the exterior, clearing heat and removing toxicity, and synchronously strengthening the body resistance and eliminating pathogenic factors, and has the maximum prevention effect on viral pneumonia such as novel coronavirus and the like and viral influenza such as influenza A and the like (the novel coronavirus pneumonia which is abused in recent years still belongs to the category of traditional Chinese medicine epidemic diseases or epidemic diseases).
(3) Feasible emergency practicability
The raw medicinal materials used in the tea beverage composition belong to traditional Chinese medicinal materials in a list of articles which are food and medicine and a list of articles which can be used for health-care food, so that the safety and effectiveness of the traditional Chinese medicinal materials in the two lists are approved by the national food and drug administration, and the traditional Chinese medicinal materials can be put into production for record management according to the requirements of the food safety law and the requirements of health-care food (functional food), and do not need to be registered and managed. Compared with the existing traditional Chinese medicine prevention prescription for respiratory tract exogenous diseases, the tea drink composition can avoid registration and supervision on health-care food or medicines in the aspect of preventing and controlling sudden large-scale epidemic caused by respiratory tract exogenous diseases and related diseases, so that rapid emergency response can be carried out, and feasible emergency practicability of the composition can be fully embodied.
In conclusion, the tea drink composition provided by the invention is used as a health food, has good edible safety, outstanding compatibility pertinence and feasible emergency practicability, is suitable for susceptible people to prevent respiratory tract external infection, particularly can avoid registration supervision on health food or medicines when large-scale epidemic situations caused by related diseases occur suddenly, and can be put into production quickly and respond to epidemic situation prevention and control needs quickly. Therefore, the method has obvious benefits or remarkable progress compared with the existing novel traditional Chinese medicine preventive prescription or preventive scheme for the coronary pneumonia.
Detailed Description
The present invention will be described in further detail with reference to specific embodiments.
Example 1
The tea beverage composition formula granule for health food of the embodiment is prepared from the following components: 15g of astragalus, 10g of bighead atractylodes rhizome, 10g of mulberry leaf, 10g of perilla leaf, 10g of honeysuckle flower, 10g of platycodon root, 10g of figwort root and 5g of liquorice.
The preparation method comprises the following steps: mixing the single medicine formula granules purchased from the market according to the proportion to obtain the formula granule electuary.
From 3 months and 18 days in 2022, the tea drink composition formula granule prepared in the embodiment 1 of the invention is distributed to 30 medical personnel taking part in the nucleic acid detection of the novel coronavirus or the work of fever clinic to take, and no adverse reaction and respiratory tract exogenous diseases (including viral cold (including influenza A) and viral pneumonia (including novel coronavirus)) are found to occur to the medical personnel taking the tea drink composition. The specific situation is as follows:
1. subject data
30 medical staff members who did not suffer from respiratory tract exogenous diseases and have negative new coronavirus detection and participated in nucleic acid detection or in fever clinics in about 1 week, wherein 9 male patients and 21 female patients have the age of 22-55 years. The subjects did not take other antiviral or anti-cold drugs during the period of taking the tea beverage composition formula granule of the invention.
2. Method of administration
The tea drink composition prepared in the embodiment 1 is prepared into granules, a proper amount of hot water is added, and the mixture is stirred and melted to be taken, wherein the tea drink composition is taken for 2 times in 1 day and 1 dose in 1 time for 7 days continuously. If the patient is in cold condition for a long time, it can be blended with rhizoma Zingiberis recens and Bulbus Allii Fistulosi decoction or administered together with the decoction.
3. Therapeutic efficacy judgment criteria
The method has the following advantages: the subjects did not suffer from respiratory tract external infection (including viral cold (including influenza) and viral pneumonia (including novel coronavirus pneumonia)) within 1 month after taking the medicine.
And (4) invalidation: the subject can suffer from respiratory tract external infection (including viral cold (including influenza) and viral pneumonia (including novel coronavirus pneumonia) 1 or more times within 1 month after administration.
4. Results
All subjects have no respiratory tract exogenous diseases (including viral cold (including influenza) and viral pneumonia (including novel coronavirus pneumonia)) within 1 month after taking the tea beverage composition formula granule, the effective rate is 30 cases, and the effective rate is 100%.
Claims (7)
1. The tea drink composition for the health food is characterized by comprising the following main active ingredients in parts by mass: 10-20 parts of astragalus membranaceus, 5-15 parts of bighead atractylodes rhizome, 5-15 parts of folium mori, 5-15 parts of perilla leaves, 5-15 parts of honeysuckle, 5-12 parts of platycodon grandiflorum, 5-15 parts of radix scrophulariae and 3-10 parts of liquorice.
2. The tea drink composition for health food according to claim 1, wherein the dosage form of the tea drink composition includes solid dosage forms including granules, powders, tablets, effervescent tablets, capsules, pills, dripping pills or tea bags, and liquid dosage forms including decoctions, water decoctions, mixtures, oral liquids or ointments.
3. The tea drink composition for health food according to claim 2, further comprising pharmaceutically acceptable adjuvants, wherein the adjuvants are one or more of fillers, binders, disintegrants, lubricants, and one or more of flavoring agents, coloring agents, preservatives, and pharmaceutically acceptable surfactants.
4. Use of the tea drink composition for health foods according to any one of claims 1 to 3 for the preparation of health foods for preventing respiratory tract external diseases.
5. The use of claim 4, wherein the respiratory tract external infection comprises a modern-medicine epidemic and/or non-epidemic respiratory tract infectious disease.
6. The use of claim 5, wherein the respiratory infectious disease comprises viral cold, viral pneumonia.
7. The use of claim 6, wherein the viral cold comprises influenza and the viral pneumonia comprises novel coronary viral pneumonia.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210678885.5A CN115336649A (en) | 2022-06-16 | 2022-06-16 | Tea drink composition for health food and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210678885.5A CN115336649A (en) | 2022-06-16 | 2022-06-16 | Tea drink composition for health food and application thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN115336649A true CN115336649A (en) | 2022-11-15 |
Family
ID=83948830
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210678885.5A Pending CN115336649A (en) | 2022-06-16 | 2022-06-16 | Tea drink composition for health food and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN115336649A (en) |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105940777B (en) * | 2003-05-30 | 2008-01-09 | 天津帝士力投资控股集团有限公司 | A kind of antiviral Chinese medicine composition |
| CN101152507A (en) * | 2007-09-28 | 2008-04-02 | 丁文生 | Traditional Chinese medicine for treating infantile pneumonia with syndrome of lingering pathogen due to deficiency of vital qi |
| CN101744870A (en) * | 2008-12-11 | 2010-06-23 | 黄欣然 | Drug for prevention of atypical pneumonia |
| CN106387158A (en) * | 2016-08-19 | 2017-02-15 | 江西汇仁药业股份有限公司 | Health-care tea and preparation method thereof |
| CN111643562A (en) * | 2020-06-09 | 2020-09-11 | 杨洪彬 | Traditional Chinese medicine composition for preventing new coronary pneumonia and preparation method and application thereof |
| CN113144108A (en) * | 2021-02-07 | 2021-07-23 | 韦刚 | A Chinese medicinal composition for treating coronavirus and preparation method thereof |
| WO2021164344A1 (en) * | 2020-02-17 | 2021-08-26 | 广州市第八人民医院 | Traditional chinese medicine composition and use thereof in prevention and treatment of viral pneumonia |
-
2022
- 2022-06-16 CN CN202210678885.5A patent/CN115336649A/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105940777B (en) * | 2003-05-30 | 2008-01-09 | 天津帝士力投资控股集团有限公司 | A kind of antiviral Chinese medicine composition |
| CN101152507A (en) * | 2007-09-28 | 2008-04-02 | 丁文生 | Traditional Chinese medicine for treating infantile pneumonia with syndrome of lingering pathogen due to deficiency of vital qi |
| CN101744870A (en) * | 2008-12-11 | 2010-06-23 | 黄欣然 | Drug for prevention of atypical pneumonia |
| CN106387158A (en) * | 2016-08-19 | 2017-02-15 | 江西汇仁药业股份有限公司 | Health-care tea and preparation method thereof |
| WO2021164344A1 (en) * | 2020-02-17 | 2021-08-26 | 广州市第八人民医院 | Traditional chinese medicine composition and use thereof in prevention and treatment of viral pneumonia |
| CN111643562A (en) * | 2020-06-09 | 2020-09-11 | 杨洪彬 | Traditional Chinese medicine composition for preventing new coronary pneumonia and preparation method and application thereof |
| CN113144108A (en) * | 2021-02-07 | 2021-07-23 | 韦刚 | A Chinese medicinal composition for treating coronavirus and preparation method thereof |
Non-Patent Citations (3)
| Title |
|---|
| 何少明;高燕;王才鸣;赵乐;: "新型冠状病毒肺炎预防中药处方组方规律探讨", 亚太传统医药, no. 06, pages 1 - 3 * |
| 佚名: "新冠肺炎中医药预防方案，请查收！", pages 1 - 7, Retrieved from the Internet <URL:https://www.sohu.com/a/370246949_120054832> * |
| 杨灿;吕晓东;庞立健;王琳琳;丛国倩;张浩洋;王佳然;盛野;: "中药复方治疗新型冠状病毒肺炎用药规律分析", 海南医学院学报, no. 13 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101385848B (en) | Medicine for treating bronchitis | |
| CN102973801A (en) | Traditional Chinese medicine composition for treating chronic pharyngitis or tonsillitis and preparation method thereof | |
| CN102526671B (en) | Traditional Chinese medicine composition for preventing and treating cough and cold and preparation method thereof | |
| CN101254255A (en) | Traditional Chinese medicine preparation for curing cold | |
| WO2021208335A1 (en) | Traditional chinese medicine composition capable of removing toxins, dispelling dampness, and disinhibiting throat, and application thereof | |
| WO2021179505A1 (en) | Forsythia suspensa and astragalus membranaceus compound preparation, preparation method therefor and application thereof | |
| CN101816736B (en) | Chinese medicament capsule for curing nasosinusitis | |
| CN111202827A (en) | Chinese medicine for preventing influenza, SARS, bird flu and new coronary pneumonia | |
| CN116139237B (en) | A Chinese medicinal composition for preventing and treating respiratory tract infection caused by coronavirus, and its application | |
| CN115486488A (en) | Tea drink composition for common food and application thereof | |
| CN104435837A (en) | Pharmaceutical composition for treating spontaneous perspiration and night sweat | |
| CN102139051B (en) | Application of soft capsule capable of clearing heat and eliminating toxin in preparation of medicament for treating viral pneumonia | |
| CN102973758A (en) | Traditional Chinese medicine composition for treating depression | |
| CN113350429B (en) | Traditional Chinese medicine composition for preventing and treating African swine fever disease as well as preparation method and application thereof | |
| CN102526236B (en) | Pharmaceutical formulation for treating influenza and preparation method thereof | |
| CN115336649A (en) | Tea drink composition for health food and application thereof | |
| CN103006780B (en) | Traditional Chinese medicinal composition for treating allergic rhinitis and method for preparing same | |
| CN103405574B (en) | Medicinal composition for treating hypertension | |
| CN107773695A (en) | A kind of Chinese medicine for being used to treat flat wart | |
| CN101745093B (en) | Medicine for quickly treating infantile chronic diarrhea | |
| CN105343503B (en) | A kind of pharmaceutical composition that treating sphagitis and its application | |
| CN105106601A (en) | Medicinal preparation for treating acute nasopharyngitis | |
| CN115486487A (en) | Tea drink composition based on medicinal and edible traditional Chinese medicinal materials and application thereof | |
| CN104173830A (en) | Medicament for reconciling interior syndromes and relieving exterior syndromes for high fever of cold in winter and preparation method thereof | |
| CN115211479A (en) | Tea drink composition based on edible and medicinal Chinese medicinal materials and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |